The female client is diagnosed with irritable bowel syndrome (IBS). The health-care provider prescribes tegaserod (Zelnorm), a gastrointestinal agent. Which assessment data indicates the medication is...

The female client is diagnosed with irritable bowel syndrome (IBS). The health-care provider prescribes tegaserod (Zelnorm), a gastrointestinal agent. Which assessment data indicates the medication is effective?

1. The client reports daily bowel movements.

2. The client complains of “passing gas.”

3. The client reports a decrease in loose stools.

4. The client is able to eat high-fiber foods.